Japan is no longer a market foreign medical device companies can afford to treat as “difficult […]
Japan is one of the world’s most demanding healthcare markets. It is also one of the […]
Radioligand therapy is now a board-level topic in Japan, not because the science is new, but […]
Japan’s IVD sector remains highly structured and closely governed, benefiting from a mature healthcare infrastructure and […]
Some of Japan’s most forward-thinking minds gathered to scrutinise Japan’s biobank conundrum at Shonan iPark. In […]
Venturing into the heart of Medical Japan at Makuhari Messe was an exhilarating experience. Although situated […]